TKFHY yields 0.62% · JNJ yields 2.14%● Live data
📍 JNJ pulled ahead of the other in Year 5
Combined, TKFHY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TKFHY + JNJ for your $10,000?
Tekfen Holding Anonim Sirketi, together with its subsidiaries, engages in engineering and contracting, chemical, agriculture, services, and investment businesses in Turkey and internationally. The company engages in the construction of petrochemical facilities, pipelines, land and marine terminals, offshore platforms, tank farms, oil refineries, pumping stations, and power plants, as well as highways, subways, bridges, tunnels, electrical and instrumentation projects, infrastructure projects, production facilities, commercial and technical building complexes, and sports complexes. It offers mineral, special water soluble, and organic/organomineral fertilizers; and generates biogas and electricity from biogas. In addition, the company produces, distributes, and trades in seedling and sapling, as well as exports cherry, apricot, pomegranate, plum, persimmon, and figs. Further, it offers services including, terminal management, guidance, towage, agency business, free zone operations, insurance, and building and facility management. Tekfen Holding Anonim Sirketi was founded in 1956 and is based in Istanbul, Turkey.
Full TKFHY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.